NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054086

Registered date:09/04/2024

A survey study of HAE patients: mental QoL and treatment preferences

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedHereditary angioedema: HAE
Date of first enrollment2024/04/10
Target sample size100
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeThe impact and degree that HAE affects anxiety and depression as well as angioedema-related quality of life (QoL) in Japanese HAE patients: HADS, AE-QoL
Secondary Outcome1)The treatment satisfaction in Japanese HAE patients:TSQM-9 2)The impact of HAE on the work productivity and generic health status in Japanese HAE patients:EQ-5D-5L,WPAI-GH 3)Patients' most important factor for deciding medication preference for HAE in Japanese patients 4)The impacts of the demographics, clinical and disease characteristics on HADS in Japanese HAE patients

Key inclusion & exclusion criteria

Age minimum12years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaParticipants who meet any of the following exclusion criteria will be excluded from participation in this study: 1)Participants who are not members of either the HAEJ or CREATE patient groups 2)Participants who have already responded to this study via the other patient group

Related Information

Contact

public contact
Name Michael LOPRESTI
Address 13F Ochanomizu SolaCity, 4-6 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan Japan 101-0062
Telephone 050-3640-1444
E-mail m.lopresti@intage.com
Affiliation INTAGE Healthcare Inc Value & Access Department
scientific contact
Name Naoki Terasaka
Address 1-2-3 Kita-aoyama, Minato-ku, Tokyo 107-0061, Japan Japan
Telephone 070-8702-1080
E-mail Naoki.Terasaka@cslbehring.com
Affiliation CSL Behring K.K. Medical Affairs